Transfection protocol for antisense oligonucleotides affects uniformity of transfection in cell culture and

Chantal A Reed1, Eigen R Peralta, Lisa M Wenrich

  • 1Isis Pharmaceuticals, Carlsbad, CA 92008, USA. chantal_reed@isisph.com

Oligonucleotides
|March 25, 2005
PubMed

Insights

Optimizing cell transfection requires careful consideration of lipid-oligonucleotide complexes. Maintaining a constant lipid concentration ensures consistent transfection efficiency, especially at lower doses, by preventing complex loss.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biotechnology

Background:

  • Antisense oligonucleotides (ASOs) are crucial for gene silencing but require efficient delivery into cells.
  • Standard transfection protocols using a fixed lipid/oligonucleotide ratio can yield variable transfection efficiencies.
  • Low concentrations of oligonucleotide and cationic lipid often result in a significant population of untransfected cells.

Purpose of the Study:

  • To optimize the transfection of cell lines using antisense oligonucleotides.
  • To understand the factors influencing variable transfection efficiency at low oligonucleotide concentrations.
  • To develop a more consistent and effective method for delivering oligonucleotides into cells.

Main Methods:

  • Flow cytometry was used to quantify cellular accumulation of labeled oligonucleotides.
  • Various lipid/oligonucleotide ratios, lipid preparations, and cell types were investigated.
  • Lipid-oligonucleotide complexes were formed at high concentrations and then diluted to assess transfection consistency.

Main Results:

  • A fixed lipid/oligonucleotide ratio showed variable transfection efficiency dependent on oligonucleotide concentration.
  • Diluting pre-formed lipid-oligonucleotide complexes in lipid or control oligonucleotide solution resulted in constant transfection percentages.
  • This dilution method shifted mRNA target reduction dose-response curves to lower doses, indicating improved efficacy.

Conclusions:

  • The loss of active lipid-oligonucleotide complexes, possibly due to adsorption or altered physical characteristics, explains poor transfection at low doses.
  • Maintaining a constant lipid concentration during complex formation and dilution is key to achieving consistent transfection.
  • This optimized approach enhances antisense oligonucleotide delivery and gene silencing efficacy in cell lines.